Health BioMed is focused on the development, production, sales and service of diagnostic products, drug development, production, sales and distribution, and health services, and other health industry chains. There are more than ten subsidiary companies. At present, the company has installed more than four thousand (sets) of in-vitro diagnostic instruments and more than 100 sets of Beckman Coulter laboratory biochemical and immunological automated assembly lines and Wolfen HemoCELL blood coagulation automated assembly lines, and established long-term cooperation with more than 700 medical institutions. The company also produces drugs in the form of tablets, Powders, capsules, granules, eye drops, water injections, varieties include cardiovascular and cerebrovascular, mental illness, respiratory system, antipyretic and analgesic, antibiotics, etc. At present, the company has launched "amlodipine besylate tablets", "compound licorice tablets", "haloperidol tablets", "clozapine tablets", "amiodarone hydrochloride tablets" and "risperidone capsules". The company also established the Ningbo Development Zone Central Hospital, integrating medical treatment, scientific research, prevention, and health care. The company has expanded into the field of medical laboratory services, and provides medical diagnosis outsourcing services for medical institutions at all levels through the establishment of independent third-party medical laboratory. Among them, the Ningbo Haiershi Medical Laboratory is engaged in testing services in three directions: circulating tumor cell detection, personalized drug testing, and disease susceptibility gene testing;